Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Empresas ICA Profit Falls - Quick Facts

Empresas ICA S.A.B. de C.V. (ICA: Quote), the largest infrastructure company in Mexico, Friday reported first-quarter net income attributable to controlling interest of 161 million pesos or 0.21 pesos per share. This compares with net income of 821 million pesos or 1.36 pesos per share reported a year earlier.

On a per American Depositary Share, or ADS basis, earnings for the quarter were $0.09, compared to $0.42 a year ago.

Revenues for the quarter slid 27 percent to 6.9 billion pesos from 9.5 billion pesos in the prior year.

For fiscal year 2013, ICA expects revenues to rebound and increase 9 to 12 percent from 2012 level. Construction revenue is expected to recover in the second half of the year, while Concessions and Airports are expected to continue their growth.

Click here to receive FREE breaking news email alerts for Empresas ICA Sociedad Controladora SA De CV and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.